Skin Disease Spectrum (dermatic Cancer Progression) Tissue Array, 79 Cases/80 Cores|ヒト組織アレイ
掲載日情報：2015/08/07 現在Webページ番号：173890
US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Skin Disease Spectrum (dermatic Cancer Progression) Tissue Array, 79 Cases/80 Cores)をご紹介します。
※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの価格
[在庫・価格 ：2025年04月29日 10時55分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
| 詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Human Skin disease spectrum(dermatic cancer progression) tissue array, 79 cases/80 cores |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
[在庫・価格 ：2025年04月29日 10時55分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
Human Skin disease spectrum(dermatic cancer progression) tissue array, 79 cases/80 cores
文献数： 0
- 商品コード：SK805
- メーカー：USB
- 包装：1slide
- 価格：¥77,000
- 在庫：無(未発注)
- 納期：2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等：
| 説明文 | |||
|---|---|---|---|
| 法規制等 | |||
| 保存条件 | 4℃ | 法規備考 | |
| 掲載カタログ |
|
||
| 製品記事 | TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド |
||
| 関連記事 | TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして |
||
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの特長
| Microarray Panel: | Skin disease spectrum (dermatic cancer progression) tissue microarray, containing 12 cases of each skin squamous cell carcinoma, basal cell carcinoma and malignant melanoma, 10 condyloma acuminatum, 6 papilloma, 1 each of verruca vulgaris and cyst, 6 hyperplasia, 5 each of adjacent tissue, inflammation, adjacent normal tissue and normal tissue, single core per case | |
|---|---|---|
| Cores: | 80 |
 |
| Cases: | 79 | |
| Layout: | 10 cols × 8 rows | |
| Core Diameter: | 1.5 mm | |
| Thickness: | 5 µm | |
| Quality Control: | Anti-Actin confirmed | |
| Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
|
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. | |
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H and E: Hematoxylin and Eosin stained tissue array slide.
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの仕様表
| Pos | No. | Sex | Age | Organ | Pathology diagnosis | Grade | Stage | TNM | Type † |
|---|---|---|---|---|---|---|---|---|---|
| A1 | 1 | M | 34 | Skin | Squamous cell carcinoma of parietal region | 1 | II | T3N0M0 | Malignant |
| A2 | 2 | F | 64 | Skin | Squamous cell carcinoma (skeletal muscle) of left cheek | – | II | T3N0M0 | Malignant |
| A3 | 3 | M | 65 | Skin | Squamous cell carcinoma of infraorbital skin | 1 | I | T1N0M0 | Malignant |
| A4 | 4 | F | 86 | Skin | Squamous cell carcinoma of right face | 1 | I | T1N0M0 | Malignant |
| A5 | 5 | M | 37 | Skin | Squamous cell carcinoma of forehead | 1 | II | T3N0M0 | Malignant |
| A6 | 6 | F | 80 | Skin | Squamous cell carcinoma of right face | 2 | II | T2N0M0 | Malignant |
| A7 | 7 | F | 84 | Skin | Squamous cell carcinoma of right face | 2 | II | T2N0M0 | Malignant |
| A8 | 8 | M | 46 | Skin | Squamous cell carcinoma of left chest wall | 2 | II | T3N0M0 | Malignant |
| A9 | 9 | M | 73 | Skin | Squamous cell carcinoma of chest subcutaneous tissue | 2 | I | T1N0M0 | Malignant |
| A10 | 10 | M | 51 | Skin | Squamous cell carcinoma of left thigh | 2 | II | T3N0M0 | Malignant |
| B1 | 11 | M | 68 | Skin | Squamous cell carcinoma of occipitalia | 2 | II | T2N0M0 | Malignant |
| B2 | 12 | M | 78 | Skin | Squamous cell carcinoma of left cheek | 2 | I | T1N0M0 | Malignant |
| B3 | 13 | M | 70 | Skin | Basal cell carcinoma of back | – | I | T1N0M0 | Malignant |
| B4 | 14 | F | 66 | Skin | Basal cell carcinoma of nasal tip | – | I | T1N0M0 | Malignant |
| B5 | 15 | M | 48 | Skin | Basal cell carcinoma of submaxilla | – | I | T1N0M0 | Malignant |
| B6 | 16 | M | 68 | Skin | Basal cell carcinoma of left tempus | – | I | T1N0M0 | Malignant |
| B7 | 17 | M | 44 | Skin | Basal cell carcinoma of face | – | I | T1N0M0 | Malignant |
| B8 | 18 | F | 70 | Skin | Basal cell carcinoma of right upper eyelid | – | I | T1N0M0 | Malignant |
| B9 | 19 | F | 85 | Skin | Basal cell carcinoma of face | – | II | T2N0M0 | Malignant |
| B10 | 20 | M | 71 | Skin | Basal cell carcinoma of parietal region | – | II | T2N0M0 | Malignant |
| C1 | 21 | M | 48 | Skin | Basal cell carcinoma | – | II | T2N0M0 | Malignant |
| C2 | 22 | F | 82 | Skin | Basal cell carcinoma of left thigh | – | II | T2N0M0 | Malignant |
| C3 | 23 | M | 55 | Skin | Basal cell carcinoma of parietal region | – | II | T2N0M0 | Malignant |
| C4 | 24 | M | 57 | Skin | Basal cell carcinoma of parietal region | – | II | T2N0M0 | Malignant |
| C5 | 25 | M | 31 | Skin | Basal cell carcinoma of scalp | – | II | T4N0M0 | Malignant |
| C6 | 26 | F | 63 | Skin | Malignant malanoma of right heel | – | II | T4N0M0 | Malignant |
| C7 | 27 | M | 80 | Skin | Malignant malanoma of sole of right foot | – | II | T4N0M0 | Malignant |
| C8 | 28 | M | 51 | Skin | Malignant malanoma of chest wall | – | II | T4N0M0 | Malignant |
| C9 | 29 | F | 56 | Skin | Malignant malanoma of left leg | – | II | T3N0M0 | Malignant |
| C10 | 30 | M | 36 | Skin | Malignant malanoma of right chest wall | – | II | T4aN0M0 | Malignant |
| D1 | 31 | M | 52 | Skin | Malignant malanoma of abdominal part | – | II | T4N0M0 | Malignant |
| D2 | 32 | M | 51 | Skin | Malignant malanoma of left upper arm | – | III | T4N1M0 | Malignant |
| D3 | 33 | M | 61 | Skin | Malignant malanoma of right groin | – | III | T4N2M0 | Malignant |
| D4 | 34 | M | 27 | Skin | Malignant malanoma of right thigh | – | III | T3N1M0 | Malignant |
| D5 | 35 | M | 42 | Skin | Malignant malanoma of left heel | – | IV | T3N2M0 | Malignant |
| D6 | 36 | M | 65 | Skin | Malignant malanoma of sole of right foot | – | – | TxN0M0 | Malignant |
| D7 | 37 | M | 38 | Skin | Condyloma acuminatum of crissum | – | – | – | Hyperplasia |
| D8 | 38 | F | 45 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| D9 | 39 | F | 30 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| D10 | 40 | F | 29 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E1 | 41 | F | 39 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E2 | 42 | F | 28 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E3 | 43 | F | 27 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E4 | 44 | F | 51 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E5 | 45 | F | 59 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E6 | 46 | F | 31 | Vulva | Condyloma acuminatum | – | – | – | Hyperplasia |
| E7 | 47 | M | 67 | Skin | Basal cell papilloma of chest wall | – | – | – | Benign |
| E8 | 48 | M | 73 | Skin | Basal cell papilloma of left thigh | – | – | – | Benign |
| E9 | 49 | M | 70 | Skin | Basal cell papilloma | – | – | – | Benign |
| E10 | 50 | M | 40 | Skin | Basal cell papilloma of hypogastrium | – | – | – | Benign |
| F1 | 51 | F | 52 | Skin | Basal cell papilloma of left thigh | – | – | – | Benign |
| F2 | 52 | M | 79 | Skin | Basal cell papilloma of left chest wall | – | – | – | Benign |
| F3 | 53 | F | 10 | Skin | Verruca vulgaris of abdominal part | – | – | – | Hyperplasia |
| F4 | 54 | M | 49 | Skin | Epidermoid cyst of groin | – | – | – | Cyst |
| F5 | 55 | F | 50 | Skin | Hyperplasia of squamous epithelium of left foot | – | – | – | Hyperplasia |
| F6 | 56 | M | 34 | Skin | Chronic inflammation of dermatic tissue with hyperplasia of squamous epithelium of sole of left foot | – | – | – | Hyperplasia |
| F7 | 57 | M | 74 | Skin | Chronic inflammation of dermatic tissue with hyperplasia of squamous epithelium of chest wall | – | – | – | Hyperplasia |
| F8 | 58 | F | 48 | Skin | Chronic inflammation of dermatic tissue with hyperplasia of squamous epithelium of chest wall | – | – | – | Hyperplasia |
| F9 | 59 | M | 62 | Skin | Hyperplasia of squamous epithelium of leg | – | – | – | Hyperplasia |
| F10 | 60 | M | 52 | Skin | Hyperplasia of squamous epithelium of left pubis | – | – | – | Hyperplasia |
| G1 | 61 | F | 62 | Skin | Cancer adjacent tissue (chronic inflammation) of scalp | – | – | – | AT |
| G2 | 62 | M | 47 | Skin | Cancer adjacent tissue of scalp | – | – | – | AT |
| G3 | 63 | M | 66 | Skin | Cancer adjacent tissue of left preauricula | – | – | – | AT |
| G4 | 64 | M | 42 | Skin | Cancer adjacent tissue (sparse) of left waist | – | – | – | AT |
| G5 | 65 | M | 65 | Skin | Cancer adjacent tissue of buttocks | – | – | – | AT |
| G6 | 66 | M | 64 | Skin | Chronic inflammation of dermatic tissue of left leg | – | – | – | Inflammation |
| G7 | 67 | F | 46 | Skin | Chronic inflammation of dermatic tissue of abdominal wall | – | – | – | Inflammation |
| G8 | 68 | M | 79 | Skin | Chronic inflammation (keratose) of right tempus | – | – | – | Inflammation |
| G9 | 69 | F | 69 | Skin | Chronic inflammation of dermatic tissue with hyperplasia of squamous epithelium of right hand | – | – | – | Inflammation |
| G10 | 70 | M | 69 | Skin | Chronic inflammation of dermatic tissue of right neck | – | – | – | Inflammation |
| H1 | 71 | F | 42 | Skin | Cancer adjacent normal dermatic tissue of breast | – | – | – | NAT |
| H2 | 72 | M | 42 | Skin | Cancer adjacent normal dermatic tissue of left waist of No. 64 | – | – | – | NAT |
| H3 | 73 | F | 50 | Skin | Cancer adjacent normal dermatic tissue of left breast | – | – | – | NAT |
| H4 | 74 | F | 50 | Skin | Cancer adjacent normal dermatic tissue of eyebrow | – | – | – | NAT |
| H5 | 75 | F | 45 | Skin | Cancer adjacent normal dermatic tissue of eyebrow | – | – | – | NAT |
| H6 | 76 | F | 27 | Skin | Normal dermatic tissue | – | – | – | Normal |
| H7 | 77 | M | 37 | Skin | Normal dermatic tissue of abdominal part | – | – | – | Normal |
| H8 | 78 | M | 33 | Skin | Normal dermatic tissue of abdominal part | – | – | – | Normal |
| H9 | 79 | M | 50 | Skin | Normal dermatic tissue | – | – | – | Normal |
| H10 | 80 | F | 19 | Skin | Normal dermatic tissue of abdominal part | – | – | – | Normal |
| – | – | M | 58 | Skin | Malignant melanoma (tissue marker) | – | Malignant |
*For precise diagnosis, refer to pathology description.
カートに商品を
追加しました。
追加しました。
ヒト組織アレイのFAQ
カートに商品を
追加しました。
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。